Renalytix AI (RNLX)
(Delayed Data from NSDQ)
$0.19 USD
-0.02 (-10.28%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $0.19 0.00 (-0.58%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.19 USD
-0.02 (-10.28%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $0.19 0.00 (-0.58%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Zacks News
New Strong Buy Stocks for October 26th
by Zacks Equity Research
GRPN, NRIX, RNLX, ABCL and SMAR have been added to the Zacks Rank #1 (Strong Buy) List on October 26, 2023.
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
by Zacks Equity Research
Renalytix AI PLC Sponsored ADR (RNLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for October 12th
by Zacks Equity Research
BTE, AZEK, SOLO, RNLX and RSKD have been added to the Zacks Rank #1 (Strong Buy) List on October 12, 2023.
Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Renalytix AI PLC Sponsored ADR (RNLX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Momentive (MNTV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Renalytix AI PLC Sponsored ADR (RNLX) Surges 10.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Renalytix AI PLC Sponsored ADR (RNLX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Renalytix AI (RNLX) Catches Eye: Stock Jumps 7%
by Zacks Equity Research
Renalytix AI (RNLX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Company News for Nov 27, 2020
by Zacks Equity Research
Companies in the news are: WORK, DOOO, WYY, RNLX